🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
Site Reference ID/Investigator# 17841
Start Date
2009-11
Trial ID
NCT00868413
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
Pacific Oncololgy & Hematology
Start Date
2009-06
Trial ID
NCT00920855
Treatments Being Tested
TAC01-HER2 is a novel cell therapy that consists of genetically engineered ...
Status
Terminated
Location
Lurie Cancer Center - Northwestern University
Start Date
2021-04-19
Trial ID
NCT04727151
Treatments Being Tested
This open-label, international, multicenter study will investigate the safe...
Status
Completed
Location
Southern Cancer Center, PC
Start Date
2014-12-01
Trial ID
NCT02187861
Treatments Being Tested
This is a pilot clinical trial investigating the addition of haploidentical...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-10-10
Trial ID
NCT02130869
A clinical study of safety and efficacy of treatment with Nivolumab and Ben...
Status
Completed
Location
First Pavlov State Medical University of St. Petersburg
Start Date
2017-05-27
Trial ID
NCT03343652
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Terminated
Location
University of Arizona Cancer Center, Tucson
Start Date
2017-03-05
Trial ID
NCT02954406
Treatments Being Tested
This is a Phase 1, open-label, multicenter study evaluating the safety, pha...
Status
Completed
Location
Ucsd /Id# 67350
Start Date
2012-05-21
Trial ID
NCT01594229
Treatments Being Tested
The primary objective of this study is to evaluate the progression-free sur...
Status
Terminated
Location
St. Jude Heritage Healthcare Virginia K. Crosson Cancer Center
Start Date
2014-02-05
Trial ID
NCT01980888
Treatments Being Tested